Warner Chilcott plc (WCRX) Misses Q3 EPS by 1c; Lowers FY11 R&D Expense Outlook
Tweet
Share
E-mailGet Alerts WCRX Hot Sheet
Price: $22.93 --0%
Financial Fact:
INCOME BEFORE TAXES: 129M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
INCOME BEFORE TAXES: 129M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Warner Chilcott plc (NASDAQ: WCRX) reported Q3 EPS of $0.89, $0.01 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $655 million versus the consensus estimate of $655.27 million.
Warner is lowering its expectations for total R&D expense from a range of $120 million to $140 million, to a range of $110 million to $130 million, due primarily to changes in the expected timing of expenses with respect to projects under development.
Warner is lowering its expectations for total R&D expense from a range of $120 million to $140 million, to a range of $110 million to $130 million, due primarily to changes in the expected timing of expenses with respect to projects under development.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- Macrogenics (MGNX) Misses Q2 EPS by 102c
- TSS, Inc. (TSSI) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
